Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmaceuticals

Set Alert for Pharmaceuticals

Animalcare to relaunch American Regent's Adequan equine joint therapeutic in EU

American Regent Animal Health has signed an exclusive agreement with UK firm Animalcare to relaunch Adequan i.m. in Europe. 

Deals Pharmaceuticals

Quicker, cheaper, better is Dyadic motto as it eyes more animal health C1 cell line partners

Founded in 1979, Dyadic International has applied its enzyme-based innovation to multiple industries. Now, the firm is turning its attentions more to the animal health space. Animal Pharm editor Joseph Harvey spoke to the company's founder and chief executive Mark Emalfarb, as well as chief commercial officer Mathew Jones, to find out more.

Pharmaceuticals R&D

IntelGenx enters companion animal space with VetaFilm drug delivery deal

Canadian pharmaceutical films specialist IntelGenx has ventured into the animal health sector for the first time with a deal for its VetaFilm platform.

Companion Animals Pharmaceuticals

Review 2019: US witnesses bumper year of veterinary approvals, while EU achieves milestone authorizations

In 2019, both the US and Europe saw several significant approvals in animal health. Animal Pharm analyst Sian Lazell gives an overview of the most notable products that were given the green light for their commercial debuts during the year.

Product Approvals Companion Animals

CannPal enters licensing deal for microencapsulation tech, fights for CBD industry reputation

Australian firm CannPal Animal Therapeutics has agreed a licensing agreement with the Commonwealth Scientific and Industrial Research Organisation (CSIRO). 

R&D Deals

Kane completes first Chinese bluestem order, closes initial private placement offering

Canadian firm Kane Biotech has fulfilled the first major order for its bluestem pet oral care line in China.

Pharmaceuticals Companion Animals

Canadian pharma start-up enlists LEVOYA to move further into animal health

Canada's Angany is teaming up with animal health consultancy LEVOYA to help grow its veterinary immunotherapy pipeline.

Canine Pharmaceuticals

Avivagen enters partnership for China approval, expands Philippines offering

Canada's Avivagen is working with the research subsidiary of Cofco Biotechnology on the regulatory process for OxC-beta Livestock in China.

Product Approvals Pharmaceuticals

Zoono antimicrobial tech achieves equivalent of 99.99% ASF virus reduction

A pipeline candidate from Australian biotechnology firm Zoono Group has shown to be effective against African swine fever (ASF). 

R&D African swine fever

Elanco makes Australian recall after label slip

Elanco has recalled certain batches of Rumensin in Australia due to an error on the product's label.

Elanco Policy & Regulation

KindredBio goes international as Mirataz gets European approval

Kindred Biosciences' Mirataz has become the first product approved in Europe to treat cats with poor appetite resulting from chronic medical conditions.

Europe Pharmaceuticals

CSPI scrutinizes uptick in US sales of antimicrobials for food animals

A consumer group has expressed concern regarding the increase in sales of medically important antimicrobials for food animals in the US.

United States FDA
See All
UsernamePublicRestriction

Register